Biotechnology Gaithersburg

Proteome Systems Limited is an Australia-based company. The Company, along with its subsidiaries, is principally engaged in biomarker discovery for development of new diagnostics in the areas of respiratory and infectious disease, and cancer; commercialization ...

Gene Logic, headquartered in Gaithersburg, Md., has developed proprietary genomics databases and services to enable customers worldwide to discover and prioritize drug targets, identify biomarkers, predict toxicity, understand mechanisms of toxicity, and ...

ExonHit Therapeutics is a worldleading company in developing novel pharmaceuticals and diagnostics from its unique understanding of alternative RNA splicing, the process by which a single gene can lead to several proteins. The company's proprietary gene ...

DNA Technologies, Inc. (DTI) is providing quality products and services to our fellow researchers from pharmaceutical, biotechnology and biomedical research institutions. DTI's Aim is to support life sciences and pharmaceutical companies/ academic institutions ...

Quality Biological, Inc., founded in 1983, is a privately held company located in Gaithersburg, Maryland. Quality Biological provides products and supplies for the molecular biology laboratory (including buffers, and RNA and DNA reagents) and for the cell ...

NorDiag ASA is a Norway-based company active within the biotechnology sector. The Company is engaged in the provision of automated systems and tests, which are used in the diagnosis of infectious diseases and cancer. Particularly, it develops automated ...

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology ...

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first ...

Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer. The Company's core technologies exploit changes in disease-relevant ...

Genetic Therapy, Inc. (GTI), a pioneer in gene delivery technologies, is focused on developing breakthrough solutions for cancer. GTI holds a leading position in oncolytic vectors, viruses that selectively kill cancer cells, offering the prospect of effectively ...

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found ...

eENZYME provides specialty thermostable DNA polymerases and top quality PCR bioplastics for life science research laboratories and biotechnology companies. Our featured products include thermostable DNA polymerases for specialty applications, such as amplification ...

The mission of GlycoMimetics, Inc. ("GMI") is to develop novel small molecule therapeutics using a specialized platform technology based upon the roles that carbohydrates play in important biological processes. The company believes that carbohydrate mimics ...

A: EraGen was founded in 1994 as Sulfonics, Inc., a California corporation. It changed its name to EraGen Biosciences and was reincorporated in Delaware in 1999. In 2002 the company consolidated its operations from Florida to new facilities in Madison ...

Calibrant Biosystems, Inc. is a Gaithersburg, Maryland biotechnology company pioneering the discovery of novel protein drug targets and markers for the treatment and diagnosis of disease. Calibrant's unique approach to protein biomarker discovery applies ...

Sirnaomics, Inc. is a privately held Delaware corporation headquartered in Gaithersburg, Maryland, USA. Established by a group of leading scientists in the field of RNAi technology, the company has the mission of advancing RNAi technology for novel drug ...

Artesian Therapeutics, Inc is a privately-held biopharmaceutical company founded in March of 2002, to discover and develop the first generation of disease modifying and disease reversing therapeutics for the treatment of cardiovascular disease. Artesian ...

AnzenBio specializes in creating solutions for the detection of micro-biologicals and biological toxins and for the isolation, amplification, and analysis of nucleic acids. Our mission is to enhance both the effectiveness and practicality of bio-detection ...

TissueGene is developing novel therapeutic technologies to reduce the long-term, escalating pain and suffering associated with degenerative disorders. To investigate the etiology of diseases in the Post-Genomic Era, TissueGene is engaged in research spanning ...

AVT was founded by three scientific directors, formerly with Genetic Therapy, Inc., a Novartis Company, to commercialize their pivotal research in localized, ocular-based gene therapy. AVT is the only gene-based medicine company that is devoted to eye ...

Immune Control Inc. is an early-stage drug discovery and development company testing novel approaches to immune modulation using small molecule, serotonin antagonists. The Company has licensed, exclusively and worldwide, intellectual property from Drexel ...

Expression Pathology Inc. (EPI) is a private biotechnology company leading the development of innovative tissue protein analysis methods for research and diagnostic applications.

Founded in 1989, Edge BioSystems was one of the pioneers in DNA sequencing reaction cleanup systems, which led to its enormously popular PERFORMA® DTR product line. Through the years, Edge has expanded its product offering to include high-throughput DNA ...

VIRxSYS corporation is a private biotech company whose mission is to develop gene therapies using its proprietary lentiviral vector delivery system. The company is in Phase II clinical trials testing the first application of its gene therapy technology ...

Biosynexus Incorporated is a biopharmaceutical company that is commercializing a portfolio of products for the prevention and treatment of infectious diseases. The company has focused its initial efforts on developing products for the prevention and treatment ...